Wegovy beats rival drug in comparative weight loss trial

For nearly 3,400 patients with obesity, the average weight loss achieved with semaglutide (Wegovy and Ozempic) was more than twice that achieved with liraglutide (Saxenda and Victoza). 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis